BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 22719195)

  • 21. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells.
    Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL
    Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
    Jin Z; Zhao Z; Cheng Y; Dong M; Zhang X; Wang L; Fan X; Feng X; Mori Y; Meltzer SJ
    Cancer; 2013 Oct; 119(20):3604-9. PubMed ID: 23893879
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
    Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
    Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
    Li LW; Yu XY; Li XY; Guo LP; Zhou Y; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):570-3. PubMed ID: 22325214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
    Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
    Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
    Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
    Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
    Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
    J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.
    Dong SW; Zhang P; Liu YM; Cui YT; Wang S; Liang SJ; He Z; Sun P; Wang YG
    World J Gastroenterol; 2012 Feb; 18(6):576-82. PubMed ID: 22363126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of connexin 26 in human lung cancer is related to promoter methylation.
    Chen Y; Hühn D; Knösel T; Pacyna-Gengelbach M; Deutschmann N; Petersen I
    Int J Cancer; 2005 Jan; 113(1):14-21. PubMed ID: 15386363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.
    Wang JX; He YL; Zhu ST; Yang S; Zhang ST
    World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Relationship between methylation status of promoter and expression of XAF1 gene in papillary thyroid carcinoma].
    Yin DT; Chen G; Li HQ; Zheng XY; Wang YF; Zhang Y; Jiang JH; Wang QD
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1967-70. PubMed ID: 22944270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
    Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
    Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.